Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

If you’re eyeing Kenvue stock and asking yourself what to do next, you’re definitely not alone. There has been more than a ...

Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

Kenvue, maker of Tylenol, rejects proposed label changes citing “no proven link” between acetaminophen use in pregnancy and ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

Johnson & Johnson stopped selling its talc-based baby powder in the US and Canada in 2020. In 2023, it switched to a cornstarch formula. The company maintains its baby powder is safe. Its consumer ...

The big news of the month is that Kering and L’Oreal have made an alliance in which Kering is selling its beauty division to L’Oreal. Kering has some major debt to sort out somewhat urgently which ...

The U.S. Food and Drug Administration (FDA) has classified the recall of Neutrogena Makeup Remover Ultra-Soft Cleansing ...